DOCSLIB.ORG

A Aahi (Scorpion Toxin), 79–81, 146–149, 334, 393, 446–447, 450–451

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Aahi (Scorpion Toxin), 79–81, 146–149, 334, 393, 446–447, 450–451 Index A 5.4 (tamapin), 370, 374–375, 378, 501 AahI (scorpion toxin), 79–81, 146–149, 5.5 (tamapin-2), 375, 501 334, 393, 446–447, 450–451, 453, 458 6.3 (HsTx1), 352, 359, 501 AahII (scorpion toxin), 79–81, 113, 116, 15.2 (BmTx3A), 496, 505, 514 146–149, 390, 407, 446–447, 450–459, 15.6 (discrepin), 281, 282, 287, 505 462, 535 16.2 (Martentoxin), 406–407 Aah venom. See Androctonus, venoms 18.2 (TdK2), 281, 506 Acetylcholine, 69–70, 101, 103, 211, 231, 18.3 (TdK3), 281, 506 264, 279, 336, 354–356, 358, 371, 23.1 (21.1, Vm24), 519 415, 423, 513 Amount of injected venom, 35, 63–64, Acute lung injury, 73, 278, 280 67, 205–206, 211, 247, 261, 266 Acute phase proteins, 72, 89, 90, 92–93, Ananteris (scorpion), 53, 233, 248 102, 280 A. balzanii, 301, 310, 313 Acute pulmonary edema. See Pulmonary A. bianchinii, 313 edema, scorpion venom-induced A. bonito, 313 Acute respiratory distress syndrome, 73, 87, A. cusinii, 230 264, 269, 274, 278 A. evellynae, 313 Adaptations A. franckei, 313 ecological, 4 A. kuryi, 313 environmental, 39–40, 56, 532, 540 A. maranhensis, 313 to life in desert, 42–44, 65, 185 A. mauryi, 313 α-helix, 282, 360, 364, 377, 397, 422, 427, 447, Anaphylactic shock, 77, 116, 125, 127, 204, 210 448, 452, 462, 495–496, 514–515, Ancestral 548, 554 arthropod, 4 α-KTx (scorpion toxins), 263, 281, 287, 314, bioactive surface, 485 339, 359, 394–396, 416–417, 463, 493, toxin, 286 495–508, 514–515, 517–519, 553 Androctonus (scorpion), 5, 37, 41–42, 50, 65, 1.1 (charybdotoxin), 374–375, 396–397, 146, 162, 181–183, 196–197, 300, 378, 474–475, 497, 517 442–466, 540 1.3 (iberiotoxin, IbTX), 370, 374–375, A. amoreuxi, 65, 91, 182–183, 197, 442, 378, 397, 497 444–445, 465 2.1 (noxiustoxin), 374–375, 498, 513 A. australis (outdated A. australis hector), 2.2 (margatoxin), 375, 498 45, 53, 65, 70–71, 75, 79–80, 91, 94, 3.1 (kaliotoxin), 66, 359, 396, 426, 499, 517 113, 116, 146, 148–150, 155, 246, 4.1 (Ts7), 426–427 264, 386, 393, 394, 442–446, 465, 4.2 (Tsκ), 514 476, 532 4.3 (TdK1), 281, 287, 500 A. bicolor, 12, 183–184, 197, 444–445 5.1 (scyllatoxin), 374–375, 501 A. crassicauda, 28, 31, 183–185, 196–197, 5.3 (BmP05), 501, 514 328, 331–336, 342–345, 444–445, 556 # Springer Science+Business Media Dordrecht 2015 563 P. Gopalakrishnakone et al. (eds.), Scorpion Venoms, Toxinology, DOI 10.1007/978-94-007-6404-0 564 Index Androctonus (scorpion) (cont.) pharmacokinetics, 110, 118–133. (see also A. mauritanicus, 42, 48, 80, 386, 442–445, Pharmacokinetics, of venoms and 465, 556 antivenoms) toxins, 331–336, 442–466. (see also AahI polyvalent, 129, 202, 270, 345–346 (scorpion toxin); AahII (scorpion production, 78–79, 140, 164, 208, 239, toxin)) 293–294, 345–346, 443 venoms (Aah venom), 80–81, 96–99, recombinant, 140–156 450, 459, 464–465 therapy, 74, 81, 165, 202, 208–212, Andrographis paniculata, 357 239, 268, 280, 294–295, 319–320, Anionic peptides, 314, 412, 417, 432 430–431 Antibacterial Apoptosis, 72, 74, 291, 335, 361, 403 activity, effect, 45, 363–364 Aquatic, 4–6, 8, 17, 352 peptide, toxin, 113, 116, 285, 289, 509 α-scorpion toxin (α-NaTx, α-NaScTx, α-type), Antibody(ies), 64, 76–82, 110, 115, 129–130, 66, 283, 314, 318, 332–334, 336–337, 134, 140–156, 162–172, 182, 203, 373, 416, 419, 429, 446–447, 450–459, 293–294, 330, 345, 430, 452, 456–457, 465, 472–487, 552 462, 535 A-type (K+) currents, 496, 513 antigen interaction, 113, 116 Autographa californica, 377 antigen recognition epitopes, 80, 115, 133 Autoimmune disease, 486, 518 fragment, format, 77–78, 80, 115, Average speed of a particle, 117 140–156, 164 Avogadro number, 117 libraries, 142–145 Anticancer (antileukemic, antineoplastic, antitumor) activity, 291, 361, B 384, 403–404 Barringtonia acutangula, 357 Antifungal, 45, 288–289 Basic proteins (peptides), 91, 99, 359, 373, 432 Antigen, 77, 79–80, 82, 131, 143–144, Belize, scorpions of, 215, 233–236 170, 172, 295 Bengalin, 352, 361–363 binding, 130–131, 141, 149 Binding sites presenting cells, 94, 99, 103 of scorpion toxins on insect neuronal Antigenic group. See Immunological group preparations, 405, 460–461 Antihistamines, in scorpion envenomation of scorpion toxins on potassium channels, treatment, 76, 209, 211, 236, 513–515, 517 248, 345 of scorpion toxins on rat brain Anti-inflammatory, 73–75, 92–94, 98, 103, synaptosomes, 452, 461–462, 464 267, 400–401, 422, 430 of scorpion toxins on voltage-gated sodium Antimicrobial channels, 404, 457, 463–465, activity, 261, 360, 363 477, 479–482 peptides (AMPs), 314, 363–364, Bioactive (components, constituents, peptides), 412, 417, 432, 509, 536–537, 328, 330, 352, 364 550, 552, 555 Bioavailability, 110, 123–124, 163, 485 Anti-osteoporosis activity, 352, 362–363 absolute, 110 Antiscorpion relative, 123–124 antiserum, 76, 208, 356, 452 Biodistribution. See Distribution, antivenin, antivenom, 123, 277 pharmacokinetic concept policies, 37 Biodiversity. See Diversity, of scorpions venom therapy (see Antivenom, therapy) Biogeography, 6–7, 10, 16–20, 173, Antivenom, 19, 76, 80, 163–164, 166, 414 182, 192 characteristics, 115–116 Biological functions, principal, 32 effectiveness, 77, 81, 110, 129–130, Biopanning, 143–145, 149–150, 153, 155 208, 211, 268, 274, 294–295 Biota, 16 neutralizing, 80, 146, 150–151, 163–164, β-KTx (scorpion toxin), 281, 289, 314, 394, 277, 345, 372 493, 495–496, 507–509, 552 Index 565 Black scorpion, Indian. See Heterometrus B. israelis, 186, 196 bengalensis B. martensii (see Mesobuthus martensii) Blood brain barrier, 68, 88, 133, 309, 413 B. occitanus, 12, 45, 47, 53, 56, 186, BmK scorpion venom 345, 455, 486 molecular interaction of neurotoxins with B. occitanus israelis, 536, 554, 556 receptors, 404–407, 453, 483 B. occitanus mardochei, 474, 477 pharmacological and pathological B. occitanus tunetanus, 65, 79, 81, 91, modulation, 90, 397–398 99, 455, 458, 461, 465, 473, 475 toxic constituents, 373, 386–397, 454, 474, Buthus tamulus. See Hottentotta, H. tamulus 477–478, 503, 505–507, 510, 536 Book lungs, 5, 28, 35 Bothriurus (scorpion), 312 C B. araguayae, 301, 310, 313, 315 Ca2+ (calcium) channel, 418, 486 B. asper, 301, 313 scorpion toxins affecting, 65–66, 163, 441, B. bonariensis, 301, 317–318 444, 548, 550, 552–553, 555 B. rochai, 313 Caraboctonidae, 27, 496, 537 B. sooretamensis, 313 Carboniferous, 5, 12, 352 Bradykinin, 72, 96, 101–102, 418, 431 Cardiac excitation-contraction, 402 Bradykinin-potentiating peptides (BPPs), electrophysiological basis of modulation, 412, 414, 416, 418, 431, 553, 555 402–403 Brazil Cardiovascular systems production of antivenom, 163, 240 collapse, 268 scorpionism in, 19–20, 150, 217, 299–320 disorders (disturbances, dysfunctions, scropion species of, 4, 12, 263, 299–320, effects, manifestations, problems, 411–412 symptoms), 64, 67–68, 70, 96, 196, 264, Bronchoconstriction, 69, 76, 90, 92, 95, 103 266–267, 278, 313, 346, 383–384, 403 β-scorpion toxin (βNaTx, βNaScTx, β-type) modulation, 402–403 (scorpion toxin), 66, 283, 286, 314, Catabolism, 45, 112, 122 332, 334, 416, 419, 429, 446, 459–465, Catecholamines, 64, 68–71, 75, 97, 101–102, 472–487, 552 196, 231, 369, 371–370, 421, 423 β-sheet, β-strand, 281, 282, 397, 422, 425, 447, Caves, scorpions living in, 8, 39, 44, 185 452, 495, 514, 548 cDNA, 143, 286–287, 332, 346, 360, 377, BtlTx3 (scorpion toxin), 370, 376 421, 427, 446, 449–451, 453, 457, ButaIT (scorpion toxin), 370, 376–378, 485 462, 494, 532–533 Buthacus (scorpion), 182 library, 263, 328, 330, 333, 339, 377–378, B. leptochelys, 183, 185, 192, 196, 198 415, 424, 446, 463, 533–539, 550, 554 B. macrocentrus, 328, 331, 336–337, Cenozoic, 7, 16, 18 343, 556 Centruroides (scorpion), 5, 29–30, 53, 55, Buthidae 65, 115, 146, 151–155, 162, 201, biology, behavior and ecology, 30, 42–44, 205, 215–220, 225–226, 228–229, 48, 50, 52–54 233–236, 238–239, 241, 247, 250–252, family, 5, 10, 12, 17, 19, 26–27, 64, 66, 257, 266, 268–269, 275, 300, 442, 446, 146, 182–184, 188, 196, 205–206, 448, 540 215–216, 218, 226, 230, 233, 247, 250, C. anchorellus, 223, 240 251, 264, 274, 300, 312, 327–328, C. balsasensis, 239 331, 333, 339, 346, 356, 384–386, C. bani, 240 412, 444, 446, 448, 537, 548, 550 C. barbudensis, 225, 229, 240 venoms, 66, 222, 433, 442, 448–450, C. bicolor, 234 459, 496 C. edwardsii, 215, 233–237, 240, 251–252, Buthus (scorpion), 65, 162, 182, 196–198, 257, 269 300, 442, 449, 540 C. elegans, 205, 239 B. amri, 183, 186, 196 C. exilicauda, 39, 240, 246, 264 B. atlantis,33 C. exilimanus, 234 566 Index Centruroides (scorpion) (cont.) Cn2 toxin (scorpion toxin), 80, 152–155, C. fallassisimus, 234 333, 475, 479 C. gracilis, 19, 53, 218, 223, 225–226, Collision-induced dissociation (CID), 557 234–235, 240, 249 Colombia C. granosus, 234, 238 scorpionism in, 151, 245–270 C. griseus, 218, 225–227 scorpion species in, 53, 115, 162–164, C. guanensis, 223, 225, 240 235, 237–238, 240, 245–270 C. hentzi, 223 Compartment, 119–120 C. infamatus infamauts, 205, 239 blood plasma, 119–120, 126 C. insulanus, 53, 218, 226 cellular, 429 C. koasteri, 234 central volume, 131 C. limbatus, 234, 238 extracellular, 127, 318 C. limpidus limpidus, 155, 205, 239–240 extravascular, 68, 77 C. mahnerti, 234 organs, tissues, 119–120, 126 C.
Load more

Recommended publications
  • Ion Channels 3 1
    r r r Cell Signalling Biology Michael J. Berridge Module 3 Ion Channels 3 1 Module 3 Ion Channels Synopsis Ion channels have two main signalling functions: either they can generate second messengers or they can function as effectors by responding to such messengers. Their role in signal generation is mainly centred on the Ca2 + signalling pathway, which has a large number of Ca2+ entry channels and internal Ca2+ release channels, both of which contribute to the generation of Ca2 + signals. Ion channels are also important effectors in that they mediate the action of different intracellular signalling pathways. There are a large number of K+ channels and many of these function in different + aspects of cell signalling. The voltage-dependent K (KV) channels regulate membrane potential and + excitability. The inward rectifier K (Kir) channel family has a number of important groups of channels + + such as the G protein-gated inward rectifier K (GIRK) channels and the ATP-sensitive K (KATP) + + channels. The two-pore domain K (K2P) channels are responsible for the large background K current. Some of the actions of Ca2 + are carried out by Ca2+-sensitive K+ channels and Ca2+-sensitive Cl − channels. The latter are members of a large group of chloride channels and transporters with multiple functions. There is a large family of ATP-binding cassette (ABC) transporters some of which have a signalling role in that they extrude signalling components from the cell. One of the ABC transporters is the cystic − − fibrosis transmembrane conductance regulator (CFTR) that conducts anions (Cl and HCO3 )and contributes to the osmotic gradient for the parallel flow of water in various transporting epithelia.
    [Show full text]
  • Androctonus Mauretanicus Mauretanicus
    Hindawi Publishing Corporation Journal of Toxicology Volume 2012, Article ID 103608, 9 pages doi:10.1155/2012/103608 Review Article Potassium Channels Blockers from the Venom of Androctonus mauretanicus mauretanicus Marie-France Martin-Eauclaire and Pierre E. Bougis Aix-Marseille University, CNRS, UMR 7286, CRN2M, Facult´edeM´edecine secteur Nord, CS80011, Boulevard Pierre Dramard, 13344 Marseille Cedex 15, France Correspondence should be addressed to Marie-France Martin-Eauclaire, [email protected] and Pierre E. Bougis, [email protected] Received 2 February 2012; Accepted 16 March 2012 Academic Editor: Maria Elena de Lima Copyright © 2012 M.-F. Martin-Eauclaire and P. E. Bougis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. K+ channels selectively transport K+ ions across cell membranes and play a key role in regulating the physiology of excitable and nonexcitable cells. Their activation allows the cell to repolarize after action potential firing and reduces excitability, whereas channel inhibition increases excitability. In eukaryotes, the pharmacology and pore topology of several structural classes of K+ channels have been well characterized in the past two decades. This information has come about through the extensive use of scorpion toxins. We have participated in the isolation and in the characterization of several structurally distinct families of scorpion toxin peptides exhibiting different K+ channel blocking functions. In particular, the venom from the Moroccan scorpion Androctonus ffi + + mauretanicus mauretanicus provided several high-a nity blockers selective for diverse K channels (SKCa,Kv4.x, and Kv1.x K channel families).
    [Show full text]
  • (K+) Channels: a Historical Overview of Peptide Bioengineering
    Toxins 2012, 4, 1082-1119; doi:10.3390/toxins4111082 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Scorpion Toxins Specific for Potassium (K+) Channels: A Historical Overview of Peptide Bioengineering Zachary L. Bergeron and Jon-Paul Bingham * Department of Molecular Biosciences and Bioengineering, College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa, Honolulu, HI 96822, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-808-956-4864; Fax: +1-808-956-3542. Received: 14 September 2012; in revised form: 22 October 2012 / Accepted: 23 October 2012 / Published: 1 November 2012 Abstract: Scorpion toxins have been central to the investigation and understanding of the physiological role of potassium (K+) channels and their expansive function in membrane biophysics. As highly specific probes, toxins have revealed a great deal about channel structure and the correlation between mutations, altered regulation and a number of human pathologies. Radio- and fluorescently-labeled toxin isoforms have contributed to localization studies of channel subtypes in expressing cells, and have been further used in competitive displacement assays for the identification of additional novel ligands for use in research and medicine. Chimeric toxins have been designed from multiple peptide scaffolds to probe channel isoform specificity, while advanced epitope chimerization has aided in the development of novel molecular therapeutics. Peptide backbone cyclization has been utilized to enhance therapeutic efficiency by augmenting serum stability and toxin half-life in vivo as a number of K+-channel isoforms have been identified with essential roles in disease states ranging from HIV, T-cell mediated autoimmune disease and hypertension to various cardiac arrhythmias and Malaria.
    [Show full text]
  • Focus on Scorpion Toxins
    ISSN 0006-2979, Biochemistry (Moscow), 2015, Vol. 80, No. 13, pp. 1764-1799. © Pleiades Publishing, Ltd., 2015. Original Russian Text © A. I. Kuzmenkov, E. V. Grishin, A. A. Vassilevski, 2015, published in Uspekhi Biologicheskoi Khimii, 2015, Vol. 55, pp. 289-350. REVIEW Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins A. I. Kuzmenkov*, E. V. Grishin, and A. A. Vassilevski* Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia; E-mail: [email protected]; [email protected] Received June 16, 2015 Revision received July 21, 2015 Abstract—Potassium (K+) channels are a widespread superfamily of integral membrane proteins that mediate selective transport of K+ ions through the cell membrane. They have been found in all living organisms from bacteria to higher mul- ticellular animals, including humans. Not surprisingly, K+ channels bind ligands of different nature, such as metal ions, low molecular mass compounds, venom-derived peptides, and antibodies. Functionally these substances can be K+ channel pore blockers or modulators. Representatives of the first group occlude the channel pore, like a cork in a bottle, while the second group of ligands alters the operation of channels without physically blocking the ion current. A rich source of K+ channel ligands is venom of different animals: snakes, sea anemones, cone snails, bees, spiders, and scorpions. More than a half of the known K+ channel ligands of polypeptide nature are scorpion toxins (KTx), all of which are pore blockers. These com- pounds have become an indispensable molecular tool for the study of K+ channel structure and function. A recent special interest is the possibility of toxin application as drugs to treat diseases involving K+ channels or related to their dysfunction (channelopathies).
    [Show full text]
  • Role of Tonic Protein Kinase a on SK2 Channel Expression Krithika Abiraman [email protected]
    University of Connecticut OpenCommons@UConn Master's Theses University of Connecticut Graduate School 12-16-2012 Role of Tonic Protein Kinase A on SK2 Channel Expression Krithika Abiraman [email protected] Recommended Citation Abiraman, Krithika, "Role of Tonic Protein Kinase A on SK2 Channel Expression" (2012). Master's Theses. 372. https://opencommons.uconn.edu/gs_theses/372 This work is brought to you for free and open access by the University of Connecticut Graduate School at OpenCommons@UConn. It has been accepted for inclusion in Master's Theses by an authorized administrator of OpenCommons@UConn. For more information, please contact [email protected]. Role of Tonic Protein Kinase A on SK2 Channel Expression Krithika Abiraman B.Tech. Anna University, 2010 A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science at the University of Connecticut 2012 i Approval APPROVAL PAGE Master of Science Thesis Role of Tonic Protein Kinase A on SK2 Channel Expression Presented by Krithika Abiraman, B.Tech. Major Advisor ___________________________________________________ George Lykotrafitis Associate Advisor ________________________________________________ Anastasios V. Tzingounis Associate Advisor ________________________________________________ Wei Sun University of Connecticut 2012 ii Acknowledgements First of all I would like to express my sincere gratitude to my major advisor, Dr. George Lykotrafitis for giving me this opportunity and for his continued support without which this thesis would not have materialized. I am grateful for his mentorship, patience and enthusiasm. Next, I would like to thank my associate advisor Dr. Anastasios Tzingounis whose advice and support has been invaluable. I greatly appreciate his guidance, advice and help on this project.
    [Show full text]
  • Design and Synthesis of Cysteine‑Rich Peptides
    This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. Design and synthesis of cysteine‑rich peptides Qiu, Yibo 2014 Qiu, Y. (2016). Design and synthesis of cysteine‑rich peptides. Doctoral thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/62189 https://doi.org/10.32657/10356/62189 Downloaded on 07 Oct 2021 19:28:23 SGT DESIGN AND SYNTHESIS OF CYSTEINE-RICH PEPTIDES Yibo Qiu School of Biological Sciences 2014 DESIGN AND SYNTHESIS OF CYSTEINE-RICH PEPTIDES Yibo Qiu School of Biological Sciences A thesis submitted to the Nanyang Technological University in partial fulfillment of the requirement for the degree of Doctor of Philosophy 2014 Acknowledgements First of all, I would like to express my sincere gratitude to my supervisor Professor Ding Xiang Liu and my co-supervisor Professor James P. Tam for their great ideas and patient guidance throughout my PhD period. In this four-year study, they kept inspiring me with their immense knowledge, great motivation and trained me with a high standard. Their education makes the process an invaluable experience for me. It is my great pleasure to be one of their students and their training will always drive me to become better in my lifetime. My appreciation also goes to Professor Chuan-Fa Liu for his encouragements and technical support during this project. He always offers me practical instructions and professional advices when I need help. I also would like to thank Professor Siu Kwan Sze and Professor Kathy Qian Luo for their help on the mass spectrometry and bioassays.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0184685 A1 Zavala, JR
    US 20100184685A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0184685 A1 Zavala, JR. et al. (43) Pub. Date: Jul. 22, 2010 (54) SYSTEMS AND METHODS FORTREATING Publication Classification POST OPERATIVE, ACUTE, AND CHRONIC (51) Int. Cl. PAIN USING AN INTRA-MUSCULAR A638/16 (2006.01) CATHETERADMINISTRATED A6IP 29/00 (2006.01) COMBINATION OF A LOCAL ANESTHETIC A6M 25/00 (2006.01) AND ANEUROTOXIN PROTEIN (52) U.S. Cl. ........................................... 514/12: 604/523 (57) ABSTRACT (76) Inventors: Gerardo Zavala, JR., San Antonio, TX (US); Gerardo Zavala, SR. Systems, and methods for the use of Such systems, are San Antonio, TX (US) described that allow for the administration of a combination of a Sustained release local anesthetic compound (such as bupivicaine) through a catheter based administration device Correspondence Address: and direct visualization or percutaneous injection of a neuro JACKSON WALKER LLP toxic protein compound (such as botulinum toxin) for post 901 MAIN STREET, SUITE 6000 operative and refractory treated muscle pain and discomfort DALLAS, TX 75202-3797 (US) in patients having undergone spinal Surgery and other muscle splitting or treatments aimed at improving muscle pain. The (21) Appl. No.: 12/689,381 systems utilize specific catheter-based administration proto cols and methods for placement of the catheter in association with muscles Surrounding the spine and other anatomical (22) Filed: Jan. 19, 2010 sites within the patient. The utilization of an initial bolus of a specific combination of medications (local anesthetic com Related U.S. Application Data pound and\or neurotoxic protein compound) followed by a dosage pump administration through the catheter is antici (60) Provisional application No.
    [Show full text]
  • Protection of Endogenous Therapeutic Peptides
    Europäisches Patentamt *EP001598365A1* (19) European Patent Office Office européen des brevets (11) EP 1 598 365 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: C07K 14/575, C07K 14/465, 23.11.2005 Bulletin 2005/47 A61P 25/28 (21) Application number: 05105387.4 (22) Date of filing: 17.05.2000 (84) Designated Contracting States: • Ezrin, Alan M. AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU Miami, FL 33133-4007 (US) MC NL PT SE • Holmes, Darren L. Designated Extension States: Anaheim, CA 92805 (CA) AL LT LV MK RO SI • Thibaudeau, Karen Montreal H3W 2L5 (CA) (30) Priority: 17.05.1999 US 134406 P • Milner, Peter G. 10.09.1999 US 153406 P Los Altos Hills, CA 94022 (US) 15.10.1999 US 159783 P (74) Representative: Holmberg, Martin Tor et al (62) Document number(s) of the earlier application(s) in Bergenstrahle & Lindvall AB accordance with Art. 76 EPC: P.O. Box 17704 00936023.1 / 1 105 409 118 93 Stockholm (SE) (71) Applicant: ConjuChem Inc. Remarks: Montréal Québec H2X 3Y8 (CA) This application was filed on 17-06-2005 as a divisional application to the application mentioned (72) Inventors: under INID code 62. • Bridon, Dominique P. San Francisco, CA 94123 (US) (54) Protection of endogenous therapeutic peptides (57) A method for protecting a peptide from pepti- vivo with a reactive functionality on a blood component. dase activity in vivo, the peptide being composed of be- In the next step, a covalent bond is formed between the tween 2 and 50 amino acids and having a C-terminus reactive group and a reactive functionality on a blood and an N-terminus and a C-terminus amino acid and an component to form a peptide-blood component conju- N-terminus amino acid is described.
    [Show full text]
  • An Apamin- and Scyllatoxin-Insensitive Isoform of the Human SK3 Channel
    0026-895X/04/6503-788–801$20.00 MOLECULAR PHARMACOLOGY Vol. 65, No. 3 Copyright © 2004 The American Society for Pharmacology and Experimental Therapeutics 2824/1131674 Mol Pharmacol 65:788–801, 2004 Printed in U.S.A. An Apamin- and Scyllatoxin-Insensitive Isoform of the Human SK3 Channel Oliver H. Wittekindt, Violeta Visan, Hiroaki Tomita, Faiqa Imtiaz, Jay J. Gargus, Frank Lehmann-Horn, Stephan Grissmer, and Deborah J. Morris-Rosendahl Department of Applied Physiology, University of Ulm, Ulm, Germany (O.H.W., V.V., F.L.-H., S.G.); Institute for Human Genetics and Anthropology, Albert-Ludwigs-University, Freiburg, Germany (O.H.W., D.J.M.-R.); Division of Human Genetics and Department of Pediatrics (J.J.G.), Department of Physiology and Biophysics (H.T., F.I., J.J.G.); and Department of Psychiatry and Human Behavior (H.T.), University of California at Irvine, Irvine, California; and King Faisal Medical Center, Riyadh, Saudi Arabia (F.I.) Downloaded from Received July 16, 2003; accepted November 24, 2003 This article is available online at http://molpharm.aspetjournals.org ABSTRACT Ϯ ϭ Ϯ ϭ ϩ We have isolated an hSK3 isoform from a human embryonic 0.17 0.04, n 3; hSK3_ex4, 0.17 0.05, n 3) and Rb molpharm.aspetjournals.org cDNA library that we have named hSK3_ex4. This isoform (hSK3, 0.79 Ϯ 0.04, n ϭ 3; hSK3_ex4, 0.8 Ϯ 0.07, n ϭ 3). Ba2ϩ contains a 15 amino acid insertion within the S5 to P-loop blocked both isoforms, and in both cases, the block was stron- segment.
    [Show full text]
  • Venom‑Derived Peptide Modulators of Cation‑Selective Channels : Friend, Foe Or Frenemy
    This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. Venom‑derived peptide modulators of cation‑selective channels : friend, foe or frenemy Bajaj, Saumya; Han, Jingyao 2019 Bajaj, S., & Han, J. (2019). Venom‑Derived Peptide Modulators of Cation‑Selective Channels: Friend, Foe or Frenemy. Frontiers in Pharmacology, 10, 58‑. doi:10.3389/fphar.2019.00058 https://hdl.handle.net/10356/88522 https://doi.org/10.3389/fphar.2019.00058 © 2019 Bajaj and Han. This is an open‑access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Downloaded on 30 Sep 2021 04:20:36 SGT fphar-10-00058 February 23, 2019 Time: 18:29 # 1 MINI REVIEW published: 26 February 2019 doi: 10.3389/fphar.2019.00058 Venom-Derived Peptide Modulators of Cation-Selective Channels: Friend, Foe or Frenemy Saumya Bajaj*† and Jingyao Han† Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore Ion channels play a key role in our body to regulate homeostasis and conduct electrical signals. With the help of advances in structural biology, as well as the discovery of numerous channel modulators derived from animal toxins, we are moving toward a better understanding of the function and mode of action of ion channels.
    [Show full text]
  • NOVEL BIS-QUINOLINIUM CYCLOPHANES AS Skca CHANNEL BLOCKERS
    NOVEL BIS-QUINOLINIUM CYCLOPHANES AS SKca CHANNEL BLOCKERS A thesis presented in partial fulfilment of the requirements for the Doctor of Philosophy Degree of the University of London LEJLA ARIFHODZIC Department of Chemistry University College London September 2001 ProQuest Number: U153874 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U153874 Published by ProQuest LLC(2015). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 ACKNOWLEDGMENTS I am grateful to my supervisor. Prof C.R. Ganellin, firstly, for giving me the opportunity to do this project and for all his support and invaluable advice thereafter. A very special thank you to Mr W. Tertuik for all his help and guidance during my time at UCL. Many thanks to Prof D.H. Jenkinson for performing the biological testing and for useful discussions and to Dr A. Vinter for his assistance in molecular modelling. My thanks go to many past and present members of UCL, in particular: T.Akinleminu, A.Alic, A.E.Aliev, J.E.Anderson, D.C.H.Benton, S.Corker, C.Escolano, J.Gonzales, K.J.Hale, J.Hill, F.Lerquin, J.Maxwell, F.L.Pearce, N.Penumarty, E.Power, S.Samad, A.Stones, S.Manaziar, M.Sachi, D.Yang, C.Yingiau and P.Zunszain.
    [Show full text]
  • Structure, Function and Pharmacology of Voltage-Gated Sodium Channels
    Naunyn-Schmiedeberg’s Arch Pharmacol (2000) 362:453–479 DOI 10.1007/s002100000319 REVIEW ARTICLE Helena Denac · Meike Mevissen · Günter Scholtysik Structure, function and pharmacology of voltage-gated sodium channels Received: 11 April 2000 / Accepted: 4 July 2000 / Published online: 24 August 2000 © Springer-Verlag 2000 Abstract Voltage-gated sodium channels (VGSCs) are SkM1 (µ1) skeletal muscle Na+ channel isoform-1 · responsible for the initial inwards current during the de- SkM2 skeletal muscle Na+ channel isoform-2 · STX polarisation phase of action potential in excitable cells. saxitoxin · TTX tetrodotoxin · UTR untranslated region · Therefore, VGSCs are crucial for cardiac and nerve func- VGSC voltage-gated sodium channel tion, since the action potential of nerves and muscle can- not occur without them. Their importance in generation and transmission of signals has been known for more than Introduction 40 years but the more recent introduction of new electro- physiological methods and application of molecular biol- Ion channels are crucial components for the activity of ogy techniques has led to an explosion of research on living cells. They are integral membrane proteins and al- many different ion channels, including VGSCs. Their ex- low particular ions to pass through them from one side of traordinary biological importance makes them logical and the membrane to the other. The plasma membrane acts as obvious targets for toxins produced by animals and plants a barrier separating the cell contents from the outside, so for attack or defence. The action of these and similar sub- that the ionic concentration inside the cell can be main- stances modulating the function of the VGSCs is interest- tained at levels considerably different from those in extra- ing with respect to their possible use in medicine or use as cellular fluids.
    [Show full text]